The Journal of Experimental Medicine
Aegean Conferences: 2009 Conferences
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online February 20, 2007
doi:10.1084/jem.20061252
The Journal of Experimental Medicine, Vol. 204, No. 3, 511-524
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Min-Oo et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2726K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Min-Oo, G.
Right arrow Articles by Gros, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Min-Oo, G.
Right arrow Articles by Gros, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

 Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus

Gundula Min-Oo1, Anny Fortin3, Giuseppina Pitari4, Mifong Tam2, Mary M. Stevenson2, and Philippe Gros1,2

1 Department of Biochemistry and 2 Centre for the Study of Host Resistance, The Research Institute of McGill University Health Centre, McGill University, Montreal H3G-1Y6, Quebec, Canada
3 Emerillon Therapeutics, Inc., Montreal H3A-1L2, Quebec, Canada
4 Dipartimento di Biologia di Base e Applicata, Universita L'Aquila, Coppito 67010, Italy

CORRESPONDENCE Philippe Gros: philippe.gros{at}mcgill.ca

Mouse strains AcB55 and AcB61 are resistant to malaria by virtue of a mutation in erythrocyte pyruvate kinase (PklrI90N). Linkage analysis in [AcB55 x A/J] F2 mice detected a second locus (Char9; logarithm of odds = 4.74) that regulates the blood-stage replication of Plasmodium chabaudi AS independently of Pklr. We characterized the 77 genes of the Char9 locus for tissue-specific expression, strain-specific alterations in gene expression, and polymorphic variants that are possibly associated with differential susceptibility. We identified Vnn1/Vnn3 as the likely candidates responsible for Char9. Vnn3/Vnn1 map within a conserved haplotype block and show expression levels that are strictly cis-regulated by this haplotype. The absence of Vnn messenger RNA expression and lack of pantetheinase protein activity in tissues are associated with susceptibility to malaria and are linked to a complex rearrangement in the Vnn3 promoter region. The A/J strain also carries a unique nonsense mutation that leads to a truncated protein. Vanin genes code for a pantetheinase involved in the production of cysteamine, a key regulator of host responses to inflammatory stimuli. Administration of cystamine in vivo partially corrects susceptibility to malaria in A/J mice, as measured by reduced blood parasitemia and decreased mortality. These studies suggest that pantetheinase is critical for the host response to malaria.

Abbreviations used: B6, C57BL/6; dNTP, dinucleotide triphosphate; GSH, glutathione; LOD, logarithm of odds; mRNA, messenger RNA; PK, pyruvate kinase; pRBC, parasitized RBC; QTL, quantitative trait locus; RCS, recombinant congenic strain; SNP, single-nucleotide polymorphic.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS